ABBOTT LABORATORIES — Director's Dealing 2018

Feb 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2018-01-31

Reporting Person: Blaser Brian J (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-31	Common shares without par value	M	27733	$22.3919	Acquired	156587	Direct
2018-01-31	Common shares without par value	S	890	$62.235	Disposed	155697	Direct
2018-01-31	Common shares without par value	S	500	$62.24	Disposed	155197	Direct
2018-01-31	Common shares without par value	S	1798	$62.245	Disposed	153399	Direct
2018-01-31	Common shares without par value	S	6400	$62.25	Disposed	146999	Direct
2018-01-31	Common shares without par value	S	2931	$62.255	Disposed	144068	Direct
2018-01-31	Common shares without par value	S	4613	$62.26	Disposed	139455	Direct
2018-01-31	Common shares without par value	S	2501	$62.265	Disposed	136954	Direct
2018-01-31	Common shares without par value	S	5660	$62.27	Disposed	131294	Direct
2018-01-31	Common shares without par value	S	1340	$62.275	Disposed	129954	Direct
2018-01-31	Common shares without par value	S	400	$62.28	Disposed	129554	Direct
2018-01-31	Common shares without par value	S	600	$62.285	Disposed	128954	Direct
2018-01-31	Common shares without par value	S	100	$62.29	Disposed	128854	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-31	Option (right to buy)	$22.3919	M	27733	Disposed	2021-02-17	Common shares (27733)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.